Results 51 to 60 of about 138,095 (212)

PB2240: SILENT GLOBIN MUTATIONS. 10 YEARS REFERRALS FOR GENETIC COUNSELING.

HemaSphere, 2022
S. Theodoridou, A. Teli, E. Boutou, E.-E. Delaki, E. Yfanti, V. Efthimia, E. Zarkada, A. Balassopoulou   +7 more
doaj   +1 more source

PB2541: RARE CAP +41 TO +44 [HBB:C.11_-8DELAAAC]/NI MUTATION IN THE 5;UTR OF THE Β GLOBIN GENE IN A GREEK MALE AND GENETIC COUNSELING.

HemaSphere, 2023
Stamatia Theodoridou, Evaggelia-Eleni Delaki, Eleni Yfanti, Aikaterini Teli, Genovefa Mantzou, Christina Karipidou, Maria Dimopoulou   +6 more
doaj   +1 more source

PAIN MANAGEMENT IN PATIENTS WITH SICKLE CELL DISEASE – A REVIEW [PDF]

European Medical Journal Hematology, 2013
Pain is defined, by the International Association for the Study of Pain (IASP), as an ‘unpleasant sensitive and emotional experience, associated with or described in terms of tissue lesion’.
Sophia Delicou, Konstantinos Maragkos
doaj  

Evaluation of physical growth of Patient WithThalassemia Major Based on NCHS criteria [PDF]

Background: Beta thalassemia major, including the conditions in which the natural growth due to complications from those diseases can be disrupted. Despite the recent advances in treating these patients, growth retardation in a significant percentage of ...
آریش, گیتی, اللهیاری, ایراندخت, سیدجوادی, مهری, مظاهری, عفت, محمدی, راحله   +4 more
core  

Effect of Assorted Globin Haplotypes and α-Thalassemia on the Clinical Heterogeneity of Hb S-β-Thalassemia

, 2019
Hemoglobinopathies and thalassemias are the most commonly encountered monogenic disorders of blood in humans, posing a major genetic and public health problem round the globe.
Kiran R. Kharat (686460), Praveen K. Sahu (1846699), Preetinanda M. Dash (6021755), Ranjeet S. Mashon (6021761), Malay B. Mukherjee (6021764), Siris Patel (6021758)   +5 more
core   +1 more source

Fluconazole as primary antifungal prophylaxis for pediatric hematopoietic stem cell transplant in antifungal NA ÆVE patients

Pediatric Hematology Oncology Journal, 2022
Amit Jain, Rajesh Patil, Ratna Sharma, Pranoti Kini, Ashutosh Walawalkar, Poulami Das, Srishti Srivastava, Leo Prince, Mamta Manglani   +8 more
doaj   +1 more source

Thalassemia and hypercoagulability

Hematology
Abstract Although the management of β-thalassemia has improved significantly, patients still suffer from many complications, including thrombotic events. A hypercoagulable state has been demonstrated in these conditions, particularly in non–transfusion-dependent β-thalassemia, because of disease-specific contributors that play a role ...
Cappellini M. D., Taher A. T., Motta I.
openaire   +2 more sources

Inherited thrombocytopenias: Early diagnosis for optimum treatment

Pediatric Hematology Oncology Journal, 2022
Anagha Kulkarni, Amit Jain, Poulami Das, Krisha Shah, Ashutosh Walawalkar, Pranoti Kini, Ratna Sharm, Mamta Manglani   +7 more
doaj   +1 more source

Diagnostic Value of Fructosamine and Glycosylated Hemoglobin in Estimating Blood Glucose Level in Diabetic Patients with Thalassemia Major

Medical Laboratory Journal, 2013
Background and Objective: Diabetes mellitus is one of complications that thalassemia major patients face with. Hence, blood glucose monitoring is of vital importance to these patients.
M Kosaryan, MR, A Aliasgharian, M Mousavi, P Roshan   +4 more
doaj  

Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cells

Genome Biology
Background Beta-thalassemia is among the most common monogenic disorders, posing a major global health challenge. Editing of genetic modifiers, such as BCL11A erythroid enhancer and HBG promoters, enhances fetal hemoglobin expression and confers major ...
Nikoletta Y. Papaioannou, Petros Patsali, Julia Klermund, Panayiota L. Papasavva, Geoffroy Andrieux, Lola Koniali, Basma Naiisseh, Soteroula Christou, Maria Sitarou, Marina Kleanthous, Toni Cathomen, Carsten W. Lederer   +11 more
doaj   +1 more source